The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group (Q73194067)
scientific article published on 01 October 1999
Language:
(P31) (Q13442814)
(P50) (Q63819762)
(P304) 1688-1702
(P433) 10
(P478) 21
(P577) Friday, October 1, 1999
(P921) (Q187255)
(P1433) (Q15716601)
(P1476) "The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group" (language: en)
(P2093) T J Schnitzer
K Truitt
R Fleischmann
P Dalgin
Q Zeng
J Bolognese
B Seidenberg
E W Ehrich
(P2860) (Q29617192)
(Q71062251)
(Q28623540)
(Q27734207)
(Q77609041)
(Q59096214)
(Q28244623)
(Q71844026)
(Q34793764)
(Q42822738)
(Q70680902)
(Q70993464)
(Q74060229)
(Q72674958)
(Q67903664)
(Q77937806)
(Q39440579)
(Q47643186)
(Q40914450)
(Q53558680)
(Q33592813)
(Q74505008)
(Q41603966)
(Q34346674)
(Q52341998)
(Q69636095)
(Q37306896)
other details
description scientific article published on 01 October 1999

External Links